Viewing Study NCT02467920


Ignite Creation Date: 2025-12-25 @ 4:24 AM
Ignite Modification Date: 2026-03-03 @ 4:33 AM
Study NCT ID: NCT02467920
Status: COMPLETED
Last Update Posted: 2018-11-14
First Post: 2015-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM
Sponsor: Huazhong University of Science and Technology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None exenatide View
None glargine View
None aspart 30 View